TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Evaluation of a Mobile Preconception Lifestyle Programme in Couples Undergoing in Vitro Fertilisation: a Multicentre Randomized Controlled Trial (PreLiFe-RCT)
Brief Summary: The aim of the PreLiFe RCT is to assess the effects of a new mobile preconception lifestyle programme (PreLiFE-programme) for couples undergoing IVF. Couples about to start IVF will be randomized between an attention control programme or the PreLiFe-programme for 12 months or until an ongoing pregnancy is confirmed by ultrasound.This study will examine whether the PreLiFe-programme results in a higher cumulative ongoing pregnancy rate within 12 months as compared to an attention control programme. Secondary outcomes include changes in diet, physical activity, personal wellbeing, body mass index, waist circumference, quality of life and other reproductive outcomes including clinical pregnancy and time to pregnancy. Additionally, the partners' support and the feasibility of the PreLiFe-programme will be evaluated.


Options:
A: Arm Label: IVF only; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Weight reduction treatment and IVF; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Low calorie diet treatment | Intervention Type: DIETARY_SUPPLEMENT; Name: Low calorie diet treatment; Assigned to Arm(s): Weight reduction treatment and IVF
B: Arm Label: PreLiFe-programme; Type: EXPERIMENTAL; Interventions: Behavioral: PreLiFe-programme, Behavioral: Attention Control Programme | Arm Label: Attention Control; Type: OTHER; Interventions: Behavioral: Attention Control Programme | Intervention Type: BEHAVIORAL; Name: PreLiFe-programme; Assigned to Arm(s): PreLiFe-programme | Intervention Type: BEHAVIORAL; Name: Attention Control Programme; Assigned to Arm(s): Attention Control, PreLiFe-programme
C: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Lifestyle intervention | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Lifestyle intervention; Assigned to Arm(s): Intervention group
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: PEPCI group; Type: EXPERIMENTAL; Interventions: Procedure: PEPCI | Intervention Type: PROCEDURE; Name: PEPCI; Assigned to Arm(s): PEPCI group

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Pilot Cluster Randomised Controlled Trial, of an Implicit Learning Approach (ILA) Versus Standard Care, on Recovery of Mobility Following Stroke
Brief Summary: This trial will compare an Implicit Learning Approach (ILA) to usual care, during the rehabilitation of mobility post stroke.

It is a multicentre, assessor blind, cluster randomised controlled pilot trial, with embedded feasibility study. It also includes a nested qualitative evaluation, designed to explore the views of participants and therapists.


Options:
A: Arm Label: Active tDCS+ Physical Therapy; Type: ACTIVE_COMPARATOR; Interventions: Device: Active tDCS, Other: Physical Therapy | Arm Label: Sham tDCS+Physical Therapy; Type: SHAM_COMPARATOR; Interventions: Other: Physical Therapy, Device: Sham tDCS | Intervention Type: DEVICE; Name: Active tDCS; Assigned to Arm(s): Active tDCS+ Physical Therapy | Intervention Type: OTHER; Name: Physical Therapy; Assigned to Arm(s): Active tDCS+ Physical Therapy, Sham tDCS+Physical Therapy | Intervention Type: DEVICE; Name: Sham tDCS; Assigned to Arm(s): Sham tDCS+Physical Therapy
B: Arm Label: Early mobilization; Type: EXPERIMENTAL; Interventions: Other: Early mobilization | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Early mobilization; Assigned to Arm(s): Early mobilization
C: Arm Label: Real stimulation; Type: ACTIVE_COMPARATOR; Interventions: Device: tDCS (ELDITH) | Arm Label: Sham; Type: SHAM_COMPARATOR; Interventions: Device: tDCS (ELDITH) | Intervention Type: DEVICE; Name: tDCS (ELDITH); Assigned to Arm(s): Real stimulation, Sham
D: Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Implicit Learning Approach; Type: EXPERIMENTAL; Interventions: Other: Implicit Learning Approach | Intervention Type: OTHER; Name: Implicit Learning Approach; Assigned to Arm(s): Implicit Learning Approach

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effectiveness of Time-Restricted Feeding(TRF) on Overweight/Obese Women with Polycystic Ovarian Syndrome(PCOS): a Randomized Controlled Trial
Brief Summary: The aims of the present study is to examine whether Time-Restricted Feeding (TRF) is a safe and effective regimen to improve insulin resistance and decrease body weight in overweight/obese Polycystic ovary syndrome (PCOS) patients over 16 weeks compared to reduced energy restriction.


Options:
A: Arm Label: Early Time Restricted Feeding; Type: EXPERIMENTAL; Interventions: Behavioral: Time Restricted Feeding | Arm Label: Mid-day Time Restricted Feeding; Type: EXPERIMENTAL; Interventions: Behavioral: Time Restricted Feeding | Intervention Type: BEHAVIORAL; Name: Time Restricted Feeding; Assigned to Arm(s): Early Time Restricted Feeding, Mid-day Time Restricted Feeding
B: Arm Label: Alternate day fasting; Type: EXPERIMENTAL; Interventions: Other: Alternate day fasting | Intervention Type: OTHER; Name: Alternate day fasting; Assigned to Arm(s): Alternate day fasting
C: Arm Label: TRF; Type: EXPERIMENTAL; Interventions: Behavioral: Time Restricted Feeding | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Usual care | Intervention Type: BEHAVIORAL; Name: Time Restricted Feeding; Assigned to Arm(s): TRF | Intervention Type: BEHAVIORAL; Name: Usual care; Assigned to Arm(s): Usual care
D: Arm Label: Control group; Type: OTHER; Interventions: Other: control group | Arm Label: Intermittent Fasting group; Type: EXPERIMENTAL; Interventions: Other: Intermittent Fasting group | Intervention Type: OTHER; Name: Intermittent Fasting group; Assigned to Arm(s): Intermittent Fasting group | Intervention Type: OTHER; Name: control group; Assigned to Arm(s): Control group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Controlled Trial on the Effect of 400 vs. 800 IU of Vitamin D on T Regulatory Cells in Preterm Infants
Brief Summary: This study evaluate the effect of two different doses of vitamin D on T-regulatory cells in preterm infants. Half of the subjects receives 400 IU vitamin D and the other half receives 800 IU vitamin D.


Options:
A: Arm Label: 400 IU vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cholecalciferol | Arm Label: 4000 IU vitamin D; Type: ACTIVE_COMPARATOR; Interventions: Drug: Cholecalciferol | Intervention Type: DRUG; Name: Cholecalciferol; Assigned to Arm(s): 400 IU vitamin D, 4000 IU vitamin D
B: Arm Label: Vitamin D3; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Vitamin D3 | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Dietary Supplement: Placebo | Intervention Type: DIETARY_SUPPLEMENT; Name: Vitamin D3; Assigned to Arm(s): Vitamin D3 | Intervention Type: DIETARY_SUPPLEMENT; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: 400 IU Vitamin D3; Type: ACTIVE_COMPARATOR; Interventions: Dietary Supplement: Cholecalciferol (D3) or ergocalciferol (D2) | Arm Label: 400 IU Vitamin D2; Type: EXPERIMENTAL; Interventions: Dietary Supplement: Cholecalciferol (D3) or ergocalciferol (D2) | Intervention Type: DIETARY_SUPPLEMENT; Name: Cholecalciferol (D3) or ergocalciferol (D2); Assigned to Arm(s): 400 IU Vitamin D2, 400 IU Vitamin D3
D: Arm Label: Low dose; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D | Arm Label: High dose; Type: EXPERIMENTAL; Interventions: Drug: Vitamin D | Intervention Type: DRUG; Name: Vitamin D; Assigned to Arm(s): High dose, Low dose

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Use of Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis: A Randomised Trial
Brief Summary: The study is planned as a randomised control trial to study the adjuvant use of antibiotics (ceftriaxone and metronidazole) to achieve a clinical response in hospitalised patients with acute severe ulcerative colitis


Options:
A: Arm Label: Antibiotics in addition to steroids; Type: EXPERIMENTAL; Interventions: Drug: AB (antibiotics) | Arm Label: Steroids only; Type: ACTIVE_COMPARATOR; Interventions: Drug: CS (corticosteroids) Only | Arm Label: Open arm; Type: OTHER; Interventions: Drug: AB (antibiotics), Drug: CS (corticosteroids) Only | Intervention Type: DRUG; Name: AB (antibiotics); Assigned to Arm(s): Antibiotics in addition to steroids, Open arm | Intervention Type: DRUG; Name: CS (corticosteroids) Only; Assigned to Arm(s): Open arm, Steroids only
B: Arm Label: Azithromycin + Metronidazole; Type: EXPERIMENTAL; Interventions: Drug: Azithromycin + Metronidazole | Arm Label: Metronidazole; Type: ACTIVE_COMPARATOR; Interventions: Drug: Metronidazole | Intervention Type: DRUG; Name: Azithromycin + Metronidazole; Assigned to Arm(s): Azithromycin + Metronidazole | Intervention Type: DRUG; Name: Metronidazole; Assigned to Arm(s): Metronidazole
C: Arm Label: Antibiotic; Type: EXPERIMENTAL; Interventions: Drug: Ceftriaxone, Drug: Metronidazole | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Other: Placebo infusion | Intervention Type: DRUG; Name: Ceftriaxone; Assigned to Arm(s): Antibiotic | Intervention Type: DRUG; Name: Metronidazole; Assigned to Arm(s): Antibiotic | Intervention Type: OTHER; Name: Placebo infusion; Assigned to Arm(s): Placebo
D: Arm Label: Weekly SER-287, after Placebo Pre-Treat.; Type: EXPERIMENTAL; Interventions: Drug: SER-287, Drug: Placebo Pre-Treat | Arm Label: Daily placebo, after Placebo Pre-Treat.; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Drug: Placebo Pre-Treat | Arm Label: Daily SER-287, after Vanco. Pre-Treat.; Type: EXPERIMENTAL; Interventions: Drug: SER-287, Drug: Vancomycin Pre-Treat | Arm Label: Weekly SER-287, after Vanco. Pre-Treat.; Type: EXPERIMENTAL; Interventions: Drug: SER-287, Drug: Vancomycin Pre-Treat | Intervention Type: DRUG; Name: SER-287; Assigned to Arm(s): Daily SER-287, after Vanco. Pre-Treat., Weekly SER-287, after Placebo Pre-Treat., Weekly SER-287, after Vanco. Pre-Treat. | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Daily placebo, after Placebo Pre-Treat. | Intervention Type: DRUG; Name: Placebo Pre-Treat; Assigned to Arm(s): Daily placebo, after Placebo Pre-Treat., Weekly SER-287, after Placebo Pre-Treat. | Intervention Type: DRUG; Name: Vancomycin Pre-Treat; Assigned to Arm(s): Daily SER-287, after Vanco. Pre-Treat., Weekly SER-287, after Vanco. Pre-Treat.

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Peer Online Motivational Interviewing for Sexual and Gender Minority Male Survivors
Brief Summary: The study will conduct a randomized comparative effectiveness trial of peer-facilitated, online, 6-week group Motivational Interviewing (MI) vs. Motivational Interviewing (MI) with a trauma-informed Sexual and Gender Minority (SGM) affirmative care approach.


Options:
A: Arm Label: Safety and Health Experiences Program; Type: EXPERIMENTAL; Interventions: Behavioral: SHE | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: SHE; Assigned to Arm(s): Safety and Health Experiences Program
B: Arm Label: CBT for PTSD; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Therapy for PTSD | Arm Label: Imagery Rehearsal Therapy + CBT for PTSD; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Behavioral Therapy for PTSD, Behavioral: Imagery Rehearsal Therapy | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy for PTSD; Assigned to Arm(s): CBT for PTSD, Imagery Rehearsal Therapy + CBT for PTSD | Intervention Type: BEHAVIORAL; Name: Imagery Rehearsal Therapy; Assigned to Arm(s): Imagery Rehearsal Therapy + CBT for PTSD
C: Arm Label: Motivational Interviewing; Type: EXPERIMENTAL; Interventions: Behavioral: Motivational Interviewing | Arm Label: MI with trauma-informed SGM affirmative care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Trauma-informed SGM affirmative care | Intervention Type: BEHAVIORAL; Name: Trauma-informed SGM affirmative care; Assigned to Arm(s): MI with trauma-informed SGM affirmative care | Intervention Type: BEHAVIORAL; Name: Motivational Interviewing; Assigned to Arm(s): Motivational Interviewing
D: Arm Label: 1; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Cognitive Processing Therapy | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Cognitive Processing Therapy, Behavioral: Hypnosis | Intervention Type: BEHAVIORAL; Name: Cognitive Processing Therapy; Assigned to Arm(s): 1, 2 | Intervention Type: BEHAVIORAL; Name: Hypnosis; Assigned to Arm(s): 2

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mobile Nudges to Increase Early Vaccination Coverage in Rural Areas: A Pilot Investigation in Ghana's Northern Region
Brief Summary: Despite major progress made in vaccination coverage overall, timeliness of vaccines remains a key concern in many settings. At the same time, access to mobile phones has increased rapidly, offering new opportunities to track and deliver health services. This research project uses these newly available mobile phone networks to simultaneously address two of the biggest bottlenecks in vaccine delivery: timely documentation of births, and lack of maternal effort or access to get essential vaccines. To increase documentation, investigators will train volunteers in each community to report new births via mobile phone to a central coordinator, and send small monetary rewards via mobile phone to volunteers for this reporting. To increase vaccination coverage, investigators will send reminder messages directly to mothers, and will also test small monetary rewards to volunteers and to mothers as an incentive to complete recommended vaccinations. The designs to provide vaccination encouragement will be tested through a small community randomized controlled trial in 15 selected villages in Ghana's Northern region. The primary outcome for the pilot study will be the percentage of children who received both the polio birth dose (OPV0) vaccination within two weeks of life (14 days) and the BCG vaccination within the first four weeks (28 days) of life.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Voice Reminder (Group A); Type: EXPERIMENTAL; Interventions: Behavioral: Voice Reminder (Group A) | Arm Label: Cash Incentive (Group B); Type: EXPERIMENTAL; Interventions: Behavioral: Cash Incentive (Group B) | Intervention Type: BEHAVIORAL; Name: Voice Reminder (Group A); Assigned to Arm(s): Voice Reminder (Group A) | Intervention Type: BEHAVIORAL; Name: Cash Incentive (Group B); Assigned to Arm(s): Cash Incentive (Group B)
B: Arm Label: Encouragement Arm; Type: EXPERIMENTAL; Interventions: Other: digital family planning screening and referral service | Arm Label: Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: digital family planning screening and referral service; Assigned to Arm(s): Encouragement Arm
C: Arm Label: Text Message; Type: EXPERIMENTAL; Interventions: Other: Text Message | Arm Label: Usual Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Text Message; Assigned to Arm(s): Text Message
D: Arm Label: mhealth intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Mhealth intervention | Arm Label: Standard Care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Mhealth intervention; Assigned to Arm(s): mhealth intervention

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mobile Nudges to Increase Early Vaccination Coverage in Rural Areas: A Pilot Investigation in Ghana's Northern Region
Brief Summary: Despite major progress made in vaccination coverage overall, timeliness of vaccines remains a key concern in many settings. At the same time, access to mobile phones has increased rapidly, offering new opportunities to track and deliver health services. This research project uses these newly available mobile phone networks to simultaneously address two of the biggest bottlenecks in vaccine delivery: timely documentation of births, and lack of maternal effort or access to get essential vaccines. To increase documentation, investigators will train volunteers in each community to report new births via mobile phone to a central coordinator, and send small monetary rewards via mobile phone to volunteers for this reporting. To increase vaccination coverage, investigators will send reminder messages directly to mothers, and will also test small monetary rewards to volunteers and to mothers as an incentive to complete recommended vaccinations. The designs to provide vaccination encouragement will be tested through a small community randomized controlled trial in 15 selected villages in Ghana's Northern region. The primary outcome for the pilot study will be the percentage of children who received both the polio birth dose (OPV0) vaccination within two weeks of life (14 days) and the BCG vaccination within the first four weeks (28 days) of life.


Options:
A: Arm Label: ISAP SMS; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ISAP SMS | Arm Label: No ISAP SMS; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ISAP SMS; Assigned to Arm(s): ISAP SMS
B: Arm Label: Clinic group 1; Type: EXPERIMENTAL; Interventions: Behavioral: mHealth messaging | Arm Label: Clinic group 2; Type: EXPERIMENTAL; Interventions: Behavioral: Transport Payments | Arm Label: Clinic group 3; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: mHealth messaging; Assigned to Arm(s): Clinic group 1 | Intervention Type: BEHAVIORAL; Name: Transport Payments; Assigned to Arm(s): Clinic group 2
C: Arm Label: Cell-phone assisted; Type: EXPERIMENTAL; Interventions: Device: Cell-phone | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Cell-phone; Assigned to Arm(s): Cell-phone assisted
D: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Voice Reminder (Group A); Type: EXPERIMENTAL; Interventions: Behavioral: Voice Reminder (Group A) | Arm Label: Cash Incentive (Group B); Type: EXPERIMENTAL; Interventions: Behavioral: Cash Incentive (Group B) | Intervention Type: BEHAVIORAL; Name: Voice Reminder (Group A); Assigned to Arm(s): Voice Reminder (Group A) | Intervention Type: BEHAVIORAL; Name: Cash Incentive (Group B); Assigned to Arm(s): Cash Incentive (Group B)

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Mobile Nudges to Increase Early Vaccination Coverage in Rural Areas: A Pilot Investigation in Ghana's Northern Region
Brief Summary: Despite major progress made in vaccination coverage overall, timeliness of vaccines remains a key concern in many settings. At the same time, access to mobile phones has increased rapidly, offering new opportunities to track and deliver health services. This research project uses these newly available mobile phone networks to simultaneously address two of the biggest bottlenecks in vaccine delivery: timely documentation of births, and lack of maternal effort or access to get essential vaccines. To increase documentation, investigators will train volunteers in each community to report new births via mobile phone to a central coordinator, and send small monetary rewards via mobile phone to volunteers for this reporting. To increase vaccination coverage, investigators will send reminder messages directly to mothers, and will also test small monetary rewards to volunteers and to mothers as an incentive to complete recommended vaccinations. The designs to provide vaccination encouragement will be tested through a small community randomized controlled trial in 15 selected villages in Ghana's Northern region. The primary outcome for the pilot study will be the percentage of children who received both the polio birth dose (OPV0) vaccination within two weeks of life (14 days) and the BCG vaccination within the first four weeks (28 days) of life.


Options:
A: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Voice Reminder (Group A); Type: EXPERIMENTAL; Interventions: Behavioral: Voice Reminder (Group A) | Arm Label: Cash Incentive (Group B); Type: EXPERIMENTAL; Interventions: Behavioral: Cash Incentive (Group B) | Intervention Type: BEHAVIORAL; Name: Voice Reminder (Group A); Assigned to Arm(s): Voice Reminder (Group A) | Intervention Type: BEHAVIORAL; Name: Cash Incentive (Group B); Assigned to Arm(s): Cash Incentive (Group B)
B: Arm Label: Clinic group 1; Type: EXPERIMENTAL; Interventions: Behavioral: mHealth messaging | Arm Label: Clinic group 2; Type: EXPERIMENTAL; Interventions: Behavioral: Transport Payments | Arm Label: Clinic group 3; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: mHealth messaging; Assigned to Arm(s): Clinic group 1 | Intervention Type: BEHAVIORAL; Name: Transport Payments; Assigned to Arm(s): Clinic group 2
C: Arm Label: Encouragement Arm; Type: EXPERIMENTAL; Interventions: Other: digital family planning screening and referral service | Arm Label: Control Arm; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: digital family planning screening and referral service; Assigned to Arm(s): Encouragement Arm
D: Arm Label: Nutrition messages; Type: EXPERIMENTAL; Interventions: Behavioral: SMS | Arm Label: General health messages; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: SMS | Intervention Type: BEHAVIORAL; Name: SMS; Assigned to Arm(s): General health messages, Nutrition messages

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Decision Support System for Self-management of Low Back Pain - a Randomized Controlled Trial for the selfBACK Project
Brief Summary: The intervention consists of a digital decision support system delivering a weekly plan of suggested activities that the participant can use to self-manage their low back pain (LBP) via an smartphone app.


Options:
A: Arm Label: Active Treatment; Type: EXPERIMENTAL; Interventions: Drug: Meloxicam 15 mg po QD | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Cognitive Behavioral Therapy | Intervention Type: DRUG; Name: Meloxicam 15 mg po QD; Assigned to Arm(s): Active Treatment | Intervention Type: BEHAVIORAL; Name: Cognitive Behavioral Therapy; Assigned to Arm(s): Placebo
B: Arm Label: Usual care + selfBACK; Type: EXPERIMENTAL; Interventions: Behavioral: selfBACK, Other: Usual care | Arm Label: Usual care; Type: ACTIVE_COMPARATOR; Interventions: Other: Usual care | Intervention Type: BEHAVIORAL; Name: selfBACK; Assigned to Arm(s): Usual care + selfBACK | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Usual care, Usual care + selfBACK
C: Arm Label: usual care waiting list; Type: ACTIVE_COMPARATOR; Interventions: Other: ususal care | Arm Label: relaxation exercise; Type: EXPERIMENTAL; Interventions: Behavioral: relaxation exercise | Intervention Type: BEHAVIORAL; Name: relaxation exercise; Assigned to Arm(s): relaxation exercise | Intervention Type: OTHER; Name: ususal care; Assigned to Arm(s): usual care waiting list
D: Arm Label: Multimodal pain therapy; Type: EXPERIMENTAL; Interventions: Other: Multimodal pain therapy | Arm Label: Standardized treatment.; Type: EXPERIMENTAL; Interventions: Other: Standardized treatment. | Intervention Type: OTHER; Name: Multimodal pain therapy; Assigned to Arm(s): Multimodal pain therapy | Intervention Type: OTHER; Name: Standardized treatment.; Assigned to Arm(s): Standardized treatment.

Answer: B